Herbert Loong Highlights Advances in Lung Cancer Therapies and Insights on HCC at IOHK2024
Immuno-Oncology Hong Kong 2024 Conference was held from November 23-24, 2024.
It was hosted by the Department of Clinical Oncology and Hong Kong Cancer Institute at The Chinese University of Hong Kong. The conference focused on the latest advancements in immuno-oncology, exploring topics such as immune checkpoint inhibitors, CAR-T therapies, and personalized cancer treatments. Experts discussed challenges like immune resistance, side effects, and the integration of immunotherapy with traditional treatments. It served as a key platform for sharing research, discussing clinical trial data, and fostering global collaborations in cancer immunotherapy
Herbert Loong, Chair-Elect of the International Affairs Committee, shared a post on X:
“Thanks Jonathan Spicer of McGill University for sharing his surgeon’s perspective on the role of peri-operative chemotherapy & immunotherapy in the management of lung cancer.”
He shared another post:
“Sitting through a very interesting session on hepatocellular carcinoma and biliary tract cancer at IOHK2024.
Thanks Angela Lamarca, Prof Ming Kuang and Prof Ardnt Vogel for your insights!”
Dr. Herbert H. F. Loong is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).
For more updates, Follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023